Year None202120202019201820172016 November 18, 2021 Medicenna Receives Award for Excellence in Clinical Trials in Connection with an Upcoming Presentation at the 26th Annual Meeting of the Society for Neuro-Oncology Go to November 12, 2021 Medicenna Reports Second Quarter Fiscal 2022 Financial Results and Operational Highlights Go to November 9, 2021 Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference Go to November 4, 2021 Medicenna Therapeutics to Announce Second Quarter 2022 Financial Results and Operational Highlights on Friday, November 12, 2021 Go to October 27, 2021 Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States Go to October 7, 2021 Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference Go to Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
November 18, 2021 Medicenna Receives Award for Excellence in Clinical Trials in Connection with an Upcoming Presentation at the 26th Annual Meeting of the Society for Neuro-Oncology Go to
November 12, 2021 Medicenna Reports Second Quarter Fiscal 2022 Financial Results and Operational Highlights Go to
November 4, 2021 Medicenna Therapeutics to Announce Second Quarter 2022 Financial Results and Operational Highlights on Friday, November 12, 2021 Go to
October 27, 2021 Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States Go to
October 7, 2021 Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference Go to
